Letters to the Editor

FLAG-IDA-Venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world study

Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa
Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem
Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem
Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem
Haematologica Early view Feb 5, 2026 https://doi.org/10.3324/haematol.2025.288866